1. Home
  2. ALNT vs GYRE Comparison

ALNT vs GYRE Comparison

Compare ALNT & GYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALNT
  • GYRE
  • Stock Information
  • Founded
  • ALNT 1962
  • GYRE 2002
  • Country
  • ALNT United States
  • GYRE United States
  • Employees
  • ALNT N/A
  • GYRE N/A
  • Industry
  • ALNT Electrical Products
  • GYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALNT Industrials
  • GYRE Health Care
  • Exchange
  • ALNT Nasdaq
  • GYRE Nasdaq
  • Market Cap
  • ALNT 791.9M
  • GYRE 897.1M
  • IPO Year
  • ALNT N/A
  • GYRE N/A
  • Fundamental
  • Price
  • ALNT $46.18
  • GYRE $8.20
  • Analyst Decision
  • ALNT Buy
  • GYRE Strong Buy
  • Analyst Count
  • ALNT 1
  • GYRE 1
  • Target Price
  • ALNT $35.00
  • GYRE $18.00
  • AVG Volume (30 Days)
  • ALNT 160.3K
  • GYRE 96.4K
  • Earning Date
  • ALNT 11-05-2025
  • GYRE 08-11-2025
  • Dividend Yield
  • ALNT 0.26%
  • GYRE N/A
  • EPS Growth
  • ALNT N/A
  • GYRE N/A
  • EPS
  • ALNT 0.85
  • GYRE 0.02
  • Revenue
  • ALNT $519,604,000.00
  • GYRE $102,189,000.00
  • Revenue This Year
  • ALNT $3.38
  • GYRE $21.04
  • Revenue Next Year
  • ALNT $3.97
  • GYRE $89.64
  • P/E Ratio
  • ALNT $53.96
  • GYRE $177.73
  • Revenue Growth
  • ALNT N/A
  • GYRE N/A
  • 52 Week Low
  • ALNT $16.91
  • GYRE $6.11
  • 52 Week High
  • ALNT $48.22
  • GYRE $19.00
  • Technical
  • Relative Strength Index (RSI)
  • ALNT 57.60
  • GYRE 53.35
  • Support Level
  • ALNT $43.82
  • GYRE $7.55
  • Resistance Level
  • ALNT $46.65
  • GYRE $8.56
  • Average True Range (ATR)
  • ALNT 1.45
  • GYRE 0.51
  • MACD
  • ALNT -0.23
  • GYRE 0.01
  • Stochastic Oscillator
  • ALNT 55.98
  • GYRE 66.36

About ALNT Allient Inc.

Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Share on Social Networks: